NCT04157985 2025-12-11Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid TumorsUniversity of PittsburghPhase 3 Completed161 enrolled
NCT02563002 2024-10-03KEYNOTE-177Merck Sharp & Dohme LLCPhase 3 Completed307 enrolled 16 charts 2 FDA